Srivichaivejvivat Toekomstige groei

Future criteriumcontroles 2/6

Srivichaivejvivat zal naar verwachting groeien in winst en omzet met respectievelijk 4% en 7.1% per jaar. De winst per aandeel zal naar verwachting groeien met 1.6% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 9.8% zijn.

Belangrijke informatie

4.0%

Groei van de winst

1.6%

Groei van de winst per aandeel

Healthcare winstgroei	10.6%
Inkomstengroei	7.1%
Toekomstig rendement op eigen vermogen	9.8%
Dekking van analisten	Low
Laatst bijgewerkt	22 Oct 2024

Recente toekomstige groei-updates

Geen updates

Recent updates

Winst- en omzetgroeiprognoses

SET:VIH - Toekomstschattingen van analisten en financiële gegevens uit het verleden (THB Millions )
Datum	Inkomsten	Inkomsten	Vrije kasstroom	Geldmiddelen uit operationele activiteiten	Gem. Aantal analisten
12/31/2026	3,435	361	-245	601	1
12/31/2025	3,168	388	-1,198	594	1
12/31/2024	2,969	340	374	517	1
6/30/2024	2,876	335	253	503	N/A
3/31/2024	2,826	317	167	442	N/A
12/31/2023	2,761	284	105	384	N/A
9/30/2023	2,673	248	333	636	N/A
6/30/2023	2,677	252	672	920	N/A
3/31/2023	2,970	363	176	714	N/A
12/31/2022	3,662	697	337	940	N/A
9/30/2022	3,754	694	1,122	1,713	N/A
6/30/2022	5,181	1,461	740	1,336	N/A
3/31/2022	5,394	1,565	1,408	1,681	N/A
12/31/2021	4,730	1,255	1,285	1,460	N/A
9/30/2021	4,551	1,260	232	410	N/A
6/30/2021	2,980	462	292	471	N/A
3/31/2021	2,320	203	177	365	N/A
12/31/2020	2,290	186	118	349	N/A
9/30/2020	2,331	177	229	429	N/A
6/30/2020	2,438	201	252	463	N/A
3/31/2020	2,537	208	225	458	N/A
12/31/2019	2,503	200	154	384	N/A
9/30/2019	2,417	169	25	279	N/A
6/30/2019	2,330	155	31	273	N/A
3/31/2019	2,282	170	24	261	N/A
12/31/2018	2,259	176	38	278	N/A
9/30/2018	2,225	181	53	302	N/A
6/30/2018	2,146	162	57	298	N/A
3/31/2018	2,081	145	N/A	252	N/A
12/31/2017	1,974	125	N/A	246	N/A
9/30/2017	1,917	116	N/A	234	N/A
6/30/2017	1,879	119	N/A	210	N/A
3/31/2017	1,809	137	N/A	230	N/A
12/31/2016	1,743	153	N/A	250	N/A
9/30/2016	1,648	157	N/A	300	N/A
6/30/2016	1,503	130	N/A	265	N/A
3/31/2016	1,433	119	N/A	263	N/A
12/31/2015	1,369	101	N/A	233	N/A
9/30/2015	1,315	88	N/A	139	N/A
6/30/2015	1,289	83	N/A	163	N/A
3/31/2015	1,287	91	N/A	141	N/A
12/31/2014	1,276	94	N/A	128	N/A
9/30/2014	1,235	82	N/A	162	N/A
6/30/2014	1,197	87	N/A	150	N/A
3/31/2014	1,160	71	N/A	147	N/A
12/31/2013	1,130	61	N/A	143	N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: De verwachte winstgroei VIH ( 4% per jaar) ligt boven de spaarquote ( 2% ).

Winst versus markt: De winst van VIH ( 4% per jaar) zal naar verwachting langzamer groeien dan de markt TH ( 15.3% per jaar).

Hoge groeiwinsten: De winst van VIH zal naar verwachting groeien, maar niet aanzienlijk.

Omzet versus markt: De omzet van VIH ( 7.1% per jaar) zal naar verwachting sneller groeien dan de markt TH ( 6.4% per jaar).

Hoge groei-inkomsten: De omzet van VIH ( 7.1% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Het rendement op eigen vermogen VIH zal naar verwachting over 3 jaar laag zijn ( 9.8 %).

Srivichaivejvivat Toekomstige groei

Future criteriumcontroles 2/6

Belangrijke informatie

Recente toekomstige groei-updates

Recent updates

Srivichai Vejvivat Public Company Limited Announces Resignation of Surin Premamornkit, as the Board Director, Audit Committee and Independent Director

Second quarter 2024 earnings released: EPS: ฿0.13 (vs ฿0.10 in 2Q 2023)

Investor sentiment improves as stock rises 26%

New minor risk - Shareholder dilution

Srivichaivejvivat Public Company Limited Announces Appointment of Jessada Chor Charoenying as Board Director, Independent Director and Audit Committee Replacing Mr. Visut Montriwat

First quarter 2024 earnings released: EPS: ฿0.13 (vs ฿0.068 in 1Q 2023)

Srivichaivejvivat Public Company Limited Announces the Resignation of Visut Montriwat as the Chairman of Audit Committee and Independent Director

Upcoming dividend of ฿0.20 per share

Srivichaivejvivat Public Company Limited has filed a Follow-on Equity Offering in the amount of THB 304.354912 million.

Srivichaivejvivat Public Company Limited has filed a Follow-on Equity Offering in the amount of THB 304.354912 million.

Srivichaivejvivat Public Company Limited Approves Dividend for the year 2023, Payable on May 4, 2024

Full year 2023 earnings released: EPS: ฿0.50 (vs ฿1.22 in FY 2022)

Third quarter 2023 earnings released: EPS: ฿0.15 (vs ฿0.16 in 3Q 2022)

Second quarter 2023 earnings released

First quarter 2023 earnings released: EPS: ฿0.07 (vs ฿0.65 in 1Q 2022)

Upcoming dividend of ฿0.45 per share at 5.3% yield

Less than half of directors are independent

Second quarter 2022 earnings released: EPS: ฿0.30 (vs ฿0.48 in 2Q 2021)

First quarter 2022 earnings released: EPS: ฿0.65 (vs ฿0.11 in 1Q 2021)

Less than half of directors are independent

Upcoming dividend of ฿0.50 per share

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Srivichaivejvivat Public Company Limited Approves Dividend Payment from the Operating Results During the Year 2021, Payable on 20 May 2022

Third quarter 2021 earnings released

Investor sentiment deteriorated over the past week

Second quarter 2021 earnings released: EPS ฿0.48 (vs ฿0.028 in 2Q 2020)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS ฿0.11 (vs ฿0.08 in 1Q 2020)

New 90-day high: ฿8.20

Upcoming Dividend of ฿0.13 Per Share

Full year 2020 earnings released: EPS ฿0.33 (vs ฿0.35 in FY 2019)

Srivichaivejvivat Public Company Limited, Annual General Meeting, Apr 16, 2021

New 90-day high: ฿7.80

New 90-day high: ฿6.95

Third quarter 2020 earnings released: EPS ฿0.10

New 90-day low: ฿5.95

New 90-day low: ฿6.10

First half earnings released

Winst- en omzetgroeiprognoses

Toekomstige groeivoorspellingen analisten

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Ontdek groeibedrijven